Glenmark tumbles on recalling Mometasone Furoate Cream from US market

09 Feb 2018 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 528.00, down by 50.05 points or 8.66% from its previous closing of Rs. 578.05 on the BSE.

The scrip opened at Rs. 544.90 and has touched a high and low of Rs. 544.90 and Rs. 524.20 respectively. So far 1,88,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 967.65 on 09-Feb-2017 and a 52 week low of Rs. 524.20 on 09-Feb-2018.

Last one week high and low of the scrip stood at Rs. 595.00 and Rs. 524.20 respectively. The current market cap of the company is Rs. 14,912.00 crore.

The promoters holding in the company stood at 46.54%, while Institutions and Non-Institutions held 37.07% and 16.40% respectively.

Glenmark Pharmaceuticals has initiated a voluntary recall of 5,136 tunes of its Mometasone Furoate Cream, USP, 0.1 per cent 45gm from the US market due to violations of the CGMP (current good manufacturing practice) regulations set up by the US Food and Drug Administration (USFDA). Mometasone Furoate Cream is used to treat skin conditions such as eczema, psoriasis, allergies, and rash.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×